GALECTIN THERAPEUTICS INC 4
4 · GALECTIN THERAPEUTICS INC · Filed Jan 2, 2014
Insider Transaction Report
Form 4
MAULDIN JOHN F
Director
Transactions
- Purchase
Common Stock
2014-01-02$8.01/sh+618$4,950→ 18,074 total
Holdings
- 4,947(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.